Cargando…
Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial
BACKGROUND: Treatment with erythropoietin is well established for anemia in chronic kidney disease patients but not well studied in acute kidney injury. METHODS: This is a multicenter, randomized, pragmatic controlled clinical trial. It included 134 hospitalized patients with anemia defined as hemog...
Autores principales: | Aoun, Mabel, Sleilaty, Ghassan, Boueri, Celine, Younes, Eliane, Gabriel, Kim, Kahwaji, Reine-Marie, Hilal, Najla, Hawi, Jenny, Araman, Rita, Chelala, Dania, Beaini, Chadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917943/ https://www.ncbi.nlm.nih.gov/pubmed/35279078 http://dx.doi.org/10.1186/s12882-022-02727-5 |
Ejemplares similares
-
Routine laboratory testing in hemodialysis: how frequently is it needed?
por: Chidiac, Claudia, et al.
Publicado: (2022) -
Association of renal resistive indices with kidney disease progression and mortality
por: Kharsa, Chloe, et al.
Publicado: (2023) -
The impact of the SARS-CoV-2 pandemic on the mental health of hemodialysis patients in Lebanon
por: Beaini, Chadia, et al.
Publicado: (2021) -
POS-925 FACTORS PREDICTIVE OF ANTI-SPIKE ANTIBODIES TITERS AFTER COVID-19 VACCINATION IN HEMODIALYSIS PATIENTS
por: AOUN, M., et al.
Publicado: (2022) -
How do Lebanese patients perceive the ideal doctor based on the CanMEDS competency framework?
por: Aoun, Mabel, et al.
Publicado: (2019)